C12N 2710/24251
Methods of production or purification of viral material
C12N2710/24251 (Methods of production or purification of viral material) appears on 6 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 9
- Assignees
- 4
- Inventors
- 17
- Latest grant
- 22 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 2 | 1 |
| 2014 | 1 | 1 |
| 2015 | 2 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Subgroups
Granted patents
Recent patents
- Oncolytic virus expressing a car T cell target and uses thereof22 Jul 2025US 12,364,724 B2City of Hope
- Continuous porcine kidney cell line constitutively expressing bovine αVβ6 integrin with increased susceptibility to foot and mouth disease virus1 Sep 2015US 9,121,010 B1The United States of America as represented by the Secretary of Agriculture
- Method for orthopoxvirus production and purification21 Apr 2015US 9,012,198 B2Transgene S. A.
- Immortalized avian cell lines and use thereof15 Jul 2014US 8,778,675 B2Transgene S. A.
- Method for orthopoxvirus production and purification17 Dec 2013US 8,609,392 B2Transgene S. A.
- Oncolytic virus expressing a car t cell target and uses thereof18 Dec 2025US 2025/0381237 A1City of Hope
- Oncolytic virus expressing a car t cell target and uses thereof9 Jul 2020US 2020/0215132 A1City of Hope
- Immortalised chicken embryonic epithelial kidney cells16 May 2019US 2019/0144831 A1Intervet Inc.
- Method for orthopoxvirus production and purification13 Mar 2014US 2014/0073033 A1Transgene S. A.
- Immortalized avian cell lines and use thereof12 Sep 2013US 2013/0236929 A1Transgene S. A.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.